|
||
“On day one of the Trump Administration, we will ask Congress to immediately deliver a full repeal of Obamacare. However, it is not enough to simply repeal this terrible legislation. We will work with Congress to make sure we have a series of reforms ready for implementation that follow free market . . . → Read More: Trumping the Affordable Care Act 
By Rory O’Neill, Hazards Magazine editor A recent Oxford University study concluding that night shift work should no longer be classified as a cause of breast cancer was based on bad science, top researchers warn. The large scale meta-analysis using data from 1.4 million women, published online on October 6th, 2016 in the Journal . . . → Read More: Cancer All-Clear For Night Work Based On Bad Science 
“Cancer Cells Spread Way Earlier Than Thought,” Sharon Begley, STAT. A highly readable article by journalist Sharon Begley in STAT discusses new research demonstrating that cancer cells are able to spread from a tumor much earlier than once believed. What’s more, these cells are more adept at forming potentially lethal metastases at distant sites (such . . . → Read More: Cancer Cells Spread Way Earlier Than Thought 
Read in PDF » The U.S. Food and Drug Administration (FDA) has increasingly used an accelerated pathway to speed up the conditional approval of drugs that treat serious medical conditions and fill an unmet need. Provisional approval hinges upon two major factors: (1) surrogate endpoints (i.e., markers of effectiveness such as a decrease . . . → Read More: Research Brief: Quality of Life, Overall Survival, and Costs of Cancer Drugs Approved Based on Surrogate Endpoints
“Congress Shouldn’t Pass FDA Reform Bills Without Addressing Patient Safety and Drug Prices,” Diana Zuckerman, The Health Care Blog. A major proposed law that alters the way the Food and Drug Administration (FDA) approves drugs and medical devices has been wending its way through Congress since 2014. The Cures bill and Senate legislation seek . . . → Read More: Congress Shouldn’t Pass FDA Reform Bills Without Addressing Patient Safety and Drug Prices When Dr. Susan Love was updating the 2015 edition of her Breast Book for a chapter titled, “When Cancer Comes Back,” she asked women with metastatic (stage IV) breast cancer what they wished the public knew about this disease. Many replied that, “the ‘early detection’ of an invasive cancer through [mammography] screening does not guarantee . . . → Read More: Inaccurate Claims about the Unequivocal Benefit of Early Detection Persist Despite Evidence to the Contrary.
This study explores the cultural construction of breast cancer within Canada’s two national newspapers. The two primary discourses in circulation were biomedicine and healthism, and both were associated with the roles of “breast cancer survivor,” “the good consumer,” and the “medical expert.” After presenting the analyses, the authors discuss the psychological, social, political, and . . . → Read More: Research Brief: Breast Cancer Representations in Canadian News Media: A Critical Discourse Analysis 
Breast Cancer Consortium heartily congratulates BCC partner Cinzia Greco on the successful completion and formal defense of her dissertation research at the École des hautes études en sciences sociales (EHESS) and CERMES3 laboratory. Her comparative research in France and Italy explores how patients and doctors view and manage post-mastectomy breast reconstruction versus cosmetic breast surgery. . . . → Read More: Breast Reconstruction in Oncology and Cosmetic Surgery: A Comparative Sociological Analysis 
Cicatrius (in)visibles (The Invisible Scars), a new book edited by Ana Porroche-Escudero, Gerard Coll-Planas, and Caterina Riba published in March (2016) by Capsa de Pandora. The book, translated into in Catalan, demystifies the dominant discourses of pink ribbon culture, analyzes androcentric, political, and economic biases in breast cancer biomedicine, and explores embodied resistance . . . → Read More: The Invisible Scars: Feminist Perspectives on Breast Cancer 
The Dr. Susan Love Research Foundation (DSLRF) — known until 2000 as The Santa Barbara Breast Cancer Institute — is known for its commitment to translating the science of breast cancer into a language laypersons can understand. Led by Dr. Susan Love, author of the widely acclaimed and influential Dr. Susan Love’s Breast Book (read . . . → Read More: Spotlight: Dr. Susan Love Research Foundation |
||
| Copyright © 2021 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||